IRLS

Related by string. IRL * * G irls . IRL IndyCar ® . IRL Menards Infiniti . IRL IndyCar Series . IRL IndyCar . IRL IndyCar Race . unified IRL IndyCar . IRL Firestone Indy . IRL SoK . Eugene Laverty IRL Parkalgar . IRL Indy . Minera IRL . Minera IRL Limited . IRL Champ Car . Minera IRL Announces . Reinbold IRL IndyCar . IRL Indy Racing . IRL Infiniti . IRL AIM MIRL . IRL Indycar Series *

Related by context. Frequent words. (Click for all words.) 76 Global Impression 76 PANSS 68 ADAS cog 65 Secondary endpoints included 61 ADHD RS 61 DAS# [002] 60 subscales 60 Secondary endpoints include 59 Rating Scale 59 Disease Activity 59 HRQoL 59 QoL 58 symptom severity 58 Secondary endpoints 58 IPSS 57 Main Outcome Measures 57 achieved statistical significance 56 placebo p = 56 CI -#.# 56 sd = 56 p = #.# [002] 56 % CI #.#-#.# [006] 55 P = .# 55 Severity 55 p = #.# [004] 54 54 mg BID 54 mg QD 54 EDSS 54 annualized relapse 54 plus methotrexate 54 placebo p 54 virologic response 53 febrile neutropenia 53 plus dexamethasone 53 HRQOL 53 ACR# [002] 53 confidence interval CI 53 MMSE 53 dyspnea 52 secondary endpoint 52 estimated glomerular filtration 52 MetS 52 fasting insulin 52 p = 52 cytogenetic response 52 ANOVA 52 demonstrated statistically significant 52 TIMI 52 histologic 51 HAQ 51 IU mL 51 CI #.#-#.# [002] 51 statistically significant improvement 51 symptomatology 51 laboratory abnormalities 51 HRSD 51 univariate 51 creatinine clearance 51 primary efficacy endpoint 51 HbA 1c 51 Solid Tumors 51 composite endpoint 50 prespecified 50 nonsignificant 50 events AEs 50 plus prednisone 50 preoperatively 50 subscale 50 hyperactivity impulsivity 49 0 document.write 49 GRADE C 49 evaluable 49 hypomagnesemia 49 glomerular filtration rate 49 systolic BP 49 ± SD 49 PASI 49 Assigns Outlooks 49 leukopenia 49 bosentan 49 RECIST criteria 49 Postoperative 49 confidence interval #.#-#.# 49 sensitivity specificity 48 RECIST 48 quartiles 48 plus ribavirin 48 ECOG 48 sustained virologic response 48 tiotropium 48 Elderly Patients 48 covariance 48 primary endpoints 48 adalimumab 48 lymphopenia 48 LVEF 48 Symptom 48 Cmax 48 peginterferon alfa 2a 48 QTc

Back to home page